ADL BIONATUR SOLUTIONS

Trading sesion


30/09/2020 15:57:39

0.5000

Last price


19.69 mill. €

Capitalisation

0.00

Dif.(%)


-75.49

% Year 2020

Last Trade

Date

30/09/2020

Hour

15:57:39

Last

0.5000

Ref.

0.5000

Dif.(%)

0.00

Volume (Shares)

38,228

Turnover (€x1000)

18.94

X
30/09/2020 16:43:29
BidAsk
OrdersVolumePricePriceVolumeOrders
16,0000.48200.50002,2502
11,7900.48000.50609,9501
11,0000.47000.51002,0001
14,0000.46600.51802,5861
12,0000.46000.52007,6572

Security

Security name

ADL BIONATUR SOLUTIONS

Ticker

ADL

ISIN

ES0184980003

NIF

A-11811163

Shares Admitted

39.389.067

Nominal

0,05 Euros

Capital Admitted

1.969.453,35 Euros

Trading

Continuo

Liquidity Provider

AURIGA GLOBAL INVESTORS S.V., S.A.

Registered Advisor

IMPULSA CAPITAL S.L.

Auditor

ERNST & YOUNG S.L.

Address

AV DESARROLLO TECNOLOGICO 11, JEREZ DE LA FRONTERA

Contact

ir@adlbionatur.com

Historical Summary

 20162017201820192020 until 29/09

Capital Admitted (thousands of euros)

2552551,9691,9691,969

Shares (x 1,000)

5,0905,09039,38939,38939,389

Period Close Price (euros)

3.11002.98001.67002.04000.5000

Period Last Price (euros)

3.11002.98001.67002.04000.5000

Period High Price (euros)

5.23003.96003.68002.50002.2800

Period Low Price (euros)

2.65001.40001.58001.63000.3500

Capitalisation (thousands of euros)

15,83015,16965,78080,35419,695

Volume (thousands of shares)

4269752,7133,6986,689

Turnover (thousands of euros)

1,6082,4796,2357,7595,989

Company Profile

Bionaturis is a biotechnology-based group offering premium solutions for human and animal health applications. The Biotech Group comprises 4 companies (Bionaturis, Biobide, ZIP Solutions, and BNT Pacific LTD) and 2 subsidiaries (BNT China Biosciences and Biobide USA) located in three different continents, being worldwide references in their markets.

The matrix company of the Group, Bionaturis -Jerez de la Frontera, Cadiz-, is devoted to Animal Health, where is positioned as a partner of choice to bring high profitable products and services to the market place. By a B2B business model Bionaturis co-develops best-in-class prescription and non-prescription products for food production animals (FPAs) and pets. Cutting-edge antigens, probiotics and feed additives, among others, are part of the broad portfolio of products to meet the main needs of a steady growing sector.

Biobide -San Sebastian- is a preclinical CRO (Contract Research Organization) worldwide leader in the use of zebrafish as animal model for efficacy and toxicity assays for the Pharma, cosmetic, nutraceutical, agri-food, and environmental sectors.

ZIP Solutions –Barcelona- is a leading company in bioprocess having a relevant portfolio of international patents around its two main assets: Splittera and Zera Vaccines (subunit 2.0 and DNA vaccines). Its business model is based on the license of its proprietary systems to tier 1 companies in the sector.

Other Relevant Information

Notices

Relevant Facts until 10/05/2020

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.